awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35667817-BEDE7B31-E700-4A0B-82E2-E7EE4A72F80F
Q35667817-BEDE7B31-E700-4A0B-82E2-E7EE4A72F80F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35667817-BEDE7B31-E700-4A0B-82E2-E7EE4A72F80F
Treatment of advanced non small cell lung cancer.
P2860
Q35667817-BEDE7B31-E700-4A0B-82E2-E7EE4A72F80F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35667817-BEDE7B31-E700-4A0B-82E2-E7EE4A72F80F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7fae8e684371114c16b4404cf5d757e22cd88849
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).